Traduction de «Traitement pharmacologique » (Français → Anglais) :

Contact lens assisted pharmacologically induced keratosteepening

pharmacotherapy [ drug therapy | drug treatment | medication therapy | medicinal therapy ]

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

nonpharmaceutical treatment [ nonpharmacological treatment ]

residue levels for pharmacologically active substances | residues of substances having a pharmacological action

pharmacological action

Death or serious disability (kernicterus) associated with failure to identify and treat hyperbilirubinemia in neonates

Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system

Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system

* A wide range of treatment services is provided by all Member States, including drug-free and medically assisted treatment.

It may in some cases be necessary to proceed to an urgent authorisation for the use of medicines or other products for combating animal diseases or ensuring animal welfare (e.g. when fighting carriers of newly appeared infectious diseases or in the pharmacological treatment of certain epidemics).

Examples of areas of potential interest are research into the pathophysiology of the disease, including epidemiological and clinical trials, research in health economics, the social sciences and humanities to help understanding of the psychological and social aspects of the disease, and research into social care models including sharing of best practices in the training of dementia caregivers, reflecting the broad consensus that patient care should not be limited to pharmacological treatment but should also include non-pharmacological approaches.

Examples of areas of potential interest are research into the pathophysiology of the disease, including epidemiological and clinical trials, research in health economics, the social sciences and humanities to help understanding of the psychological and social aspects of the disease, and research into social care models including sharing of best practices in the training of dementia caregivers, reflecting the broad consensus that patient care should not be limited to pharmacological treatment but should also include non-pharmacological approaches.